Journal for ImmunoTherapy of Cancer (Nov 2021)
378 Efficacy, safety and ancillary analyses of pembrolizumab in combination with nintedanib for the treatment of patients with relapsed advanced mesothelioma
- Capucine Baldini,
- Francois-Xavier Danlos,
- Aurélien Marabelle,
- Jean-Charles Soria,
- Christophe Massard,
- Lydie Cassard,
- Julien Adam,
- David Planchard,
- Andreea Varga,
- Gérard Zalcman,
- Nathalie Chaput-Gras,
- Matthieu Texier,
- Severine Mouraud,
- Bastien Job,
- Diane Letourneur,
- Delphine Bredel,
- Salim Laghouati,
- Nathalie Droin,
- Aurelien Parpaleix,
- Audrey Rabeau
Affiliations
- Capucine Baldini
- 5Institut de Cancérologie Gustave Roussy, Villejuif, France
- Francois-Xavier Danlos
- 1 Medical Oncology and Drug Development Department, Institut Gustave Roussy, Villejuif, France
- Aurélien Marabelle
- 17 Drug Development, Gustave Roussy Cancer Center, Villejuif, France
- Jean-Charles Soria
- Aff6 grid.14925.3b0000000122849388Gustave Roussy Villejuif France
- Christophe Massard
- 5Institut de Cancérologie Gustave Roussy, Villejuif, France
- Lydie Cassard
- Analyse Moléculaire, Modélisation et Imagerie de la Maladie Cancéreuse, Laboratoire d’Immunomonitoring en Oncologie, Gustave Roussy Institute, INSERM, CNRS, Paris-Saclay University, Villejuif, Île-de-France, France
- Julien Adam
- Pathology Department, Gustave Roussy Institute, Villejuif, Val-de-Marne, France
- David Planchard
- Department of Medical Oncology, Thoracic Unit, Gustave Roussy, Villejuif, France
- Andreea Varga
- 5Institut de Cancérologie Gustave Roussy, Villejuif, France
- Gérard Zalcman
- 2Hôpital Bichat-Claude Bernard, Assistance Publique Hôpitaux de Paris, Université de Paris. U830 INSERM “Genetics and Biology of Cancers, ART Group”, Curie Institute, Paris, France, Paris, France
- Nathalie Chaput-Gras
- 1Gustave Roussy, Villejuif, France
- Matthieu Texier
- 1Gustave Roussy, VILLEJUIF, France
- Severine Mouraud
- 2Gustave Roussy, INSERM, CLAMART, France
- Bastien Job
- 1Gustave Roussy, VILLEJUIF, France
- Diane Letourneur
- 3Gustave Roussy, ENS Lyon, Villejuif, France
- Delphine Bredel
- 2Gustave Roussy, INSERM, CLAMART, France
- Salim Laghouati
- 1Gustave Roussy, VILLEJUIF, France
- Nathalie Droin
- 1Gustave Roussy, VILLEJUIF, France
- Aurelien Parpaleix
- 1Gustave Roussy, VILLEJUIF, France
- Audrey Rabeau
- 6Institut Universitaire Oncologie, Toulouse, France
- DOI
- https://doi.org/10.1136/jitc-2021-SITC2021.378
- Journal volume & issue
-
Vol. 9,
no. Suppl 2
Abstract
No abstracts available.
